D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
COGT holding history
Cogent Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
COGT overviewAll 13F holders of COGTFull Q2 2026 holdings
- Shares (Q2 2026)
- 922,479
- Value
- $35.7M
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 922,479 | $35.7M | <0.1% | −945,910−50.6% | Reduced | Holders |
| Q1 2026 | 1,868,389 | $71.9M | 0.1% | −379,415−16.9% | Reduced | Holders |
| Q4 2025 | 2,247,804 | $79.8M | 0.1% | +716,879+46.8% | Added | Holders |
| Q3 2025 | 1,530,925 | $22.0M | <0.1% | +1,257,390+459.7% | Added | Holders |
| Q2 2025 | 273,535 | $1.96M | <0.1% | +56,004+25.7% | Added | Holders |
| Q1 2025 | 217,531 | $1.30M | <0.1% | −122,457−36.0% | Reduced | Holders |
| Q4 2024 | 339,988 | $2.65M | <0.1% | −117,240−25.6% | Reduced | Holders |
| Q3 2024 | 457,228 | $4.94M | <0.1% | +158,517+53.1% | Added | Holders |
| Q2 2024 | 298,711 | $2.52M | <0.1% | −152,521−33.8% | Reduced | Holders |
| Q1 2024 | 451,232 | $3.03M | <0.1% | +392,431+667.4% | Added | Holders |
| Q4 2023 | 58,801 | $345.8K | <0.1% | −51,725−46.8% | Reduced | Holders |
| Q3 2023 | 110,526 | $1.08M | <0.1% | −91,630−45.3% | Reduced | Holders |
| Q2 2023 | 202,156 | $2.39M | <0.1% | −259,678−56.2% | Reduced | Holders |
| Q1 2023 | 461,834 | $4.98M | <0.1% | −271,626−37.0% | Reduced | Holders |
| Q4 2022 | 733,460 | $8.48M | <0.1% | −166,613−18.5% | Reduced | Holders |
| Q3 2022 | 900,073 | $13.4M | <0.1% | +704,172+359.5% | Added | Holders |
| Q2 2022 | 195,901 | $1.77M | <0.1% | +195,901 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −25,813−100.0% | Sold out | Holders |
| Q4 2021 | 25,813 | $221.0K | <0.1% | +25,813 | New | Holders |